To include your compound in the COVID-19 Resource Center, submit it here.

Avanir Pharmaceuticals, Idec deal

AVN’s Xenerex Biosciences subsidiary acquired IDPH’s ownership interest in

Read the full 98 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE